Yiyan Zhai

434 total citations · 1 hit paper
17 papers, 197 citations indexed

About

Yiyan Zhai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yiyan Zhai has authored 17 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Yiyan Zhai's work include Single-cell and spatial transcriptomics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yiyan Zhai is often cited by papers focused on Single-cell and spatial transcriptomics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yiyan Zhai collaborates with scholars based in China and United States. Yiyan Zhai's co-authors include Jiarui Wu, Fanqin Zhang, Rui Shi, Jingyuan Zhang, Siyu Guo, Shan Lu, Xiaoyu Tao, Zhihong Huang, Xinkui Liu and Leiming You and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Medicine.

In The Last Decade

Yiyan Zhai

15 papers receiving 195 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Network pharmacology: a crucial approach in traditional Chinese medicine research

2025 33 citations Yiyan Zhai, Fanqin Zhang et al. Chinese Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yiyan Zhai China	9	110	65	59	42	27	17	197
Fanqin Zhang China	9	125 1.1×	63 1.0×	62 1.1×	45 1.1×	26 1.0×	20	229
Xiaona Lu China	10	132 1.2×	56 0.9×	61 1.0×	61 1.5×	34 1.3×	22	252
Kunrui Zhu China	6	139 1.3×	39 0.6×	36 0.6×	72 1.7×	26 1.0×	9	254
Yaqi Mo China	6	129 1.2×	36 0.6×	70 1.2×	75 1.8×	28 1.0×	9	276
Zhongqi Wang China	10	157 1.4×	56 0.9×	91 1.5×	54 1.3×	21 0.8×	25	281
Xiaomin Liu China	9	194 1.8×	72 1.1×	112 1.9×	81 1.9×	25 0.9×	19	343
Baicang Zou China	9	100 0.9×	46 0.7×	44 0.7×	31 0.7×	22 0.8×	20	219
Ahmed El Bastawisy Egypt	10	100 0.9×	55 0.8×	36 0.6×	80 1.9×	25 0.9×	17	209
Naiqiang Zhu China	10	168 1.5×	50 0.8×	82 1.4×	34 0.8×	36 1.3×	17	303

Countries citing papers authored by Yiyan Zhai

Since Specialization

Citations

This map shows the geographic impact of Yiyan Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiyan Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiyan Zhai more than expected).

Fields of papers citing papers by Yiyan Zhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiyan Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiyan Zhai. The network helps show where Yiyan Zhai may publish in the future.

Co-authorship network of co-authors of Yiyan Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Yiyan Zhai. A scholar is included among the top collaborators of Yiyan Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiyan Zhai. Yiyan Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zhai, Yiyan, Fanqin Zhang, Xiaodong Chen, et al.. (2025). Network pharmacology: a crucial approach in traditional Chinese medicine research. Chinese Medicine. 20(1). 8–8. 33 indexed citations breakdown →

Zhang, Fanqin, Xiao‐Dong Chen, Siyun Yang, et al.. (2025). Exploring the Anti-Colorectal Cancer Mechanism of Norcantharidin Through TRAF5/NF-κB Pathway Regulation and Folate-Targeted Liposomal Delivery. International Journal of Molecular Sciences. 26(4). 1450–1450.

Shi, Rui, Haojia Wang, Yiyan Zhai, et al.. (2024). Comparative effectiveness of five Chinese patent medicines for non-alcoholic fatty liver disease: A systematic review and Bayesian network meta-analysis. Phytomedicine. 135. 156124–156124. 1 indexed citations

Zhai, Yiyan, Fanqin Zhang, Jingyuan Zhang, et al.. (2024). Mechanism of norcantharidin intervention in gastric cancer: analysis based on antitumor proprietary Chinese medicine database, network pharmacology, and transcriptomics. Chinese Medicine. 19(1). 129–129. 4 indexed citations

Huang, Zhihong, Chao Wu, Fanqin Zhang, et al.. (2024). Molecular insights into gastric cancer: The impact of TGFBR2 and hsa-mir-107 revealed by microarray sequencing and bioinformatics. Computers in Biology and Medicine. 172. 108221–108221. 3 indexed citations

Tan, Yingying, Yingying Liu, Yiyan Zhai, et al.. (2024). Investigating the Potential Mechanism of Huazhi Rougan Granules Against Alcoholic Liver Disease by Network Pharmacology and Experiment. World Journal of Traditional Chinese Medicine. 10(2). 191–203. 2 indexed citations

Wang, Haojia, Rui Shi, Antony Stalin, et al.. (2024). Effectiveness of Bairui granules in the treatment of respiratory tract infections: A systematic review and meta-analysis. Medicine. 103(29). e38904–e38904.

Wang, Yixuan, Haojia Wang, Siyu Guo, et al.. (2023). Systematic review and meta-analysis on the efficacy and safety of Injectable Lentinan combined with chemotherapy in the treatment of gastric cancer. Phytomedicine. 123. 155242–155242. 11 indexed citations

Wu, Chao, Jiaqi Huang, Zhihong Huang, et al.. (2023). A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification. Computers in Biology and Medicine. 166. 107562–107562. 8 indexed citations

10.

Zhai, Yiyan, Jingyuan Zhang, Zhihong Huang, et al.. (2023). Single-cell RNA sequencing integrated with bulk RNA sequencing analysis reveals diagnostic and prognostic signatures and immunoinfiltration in gastric cancer. Computers in Biology and Medicine. 163. 107239–107239. 7 indexed citations

11.

Guo, Siyu, Xinkui Liu, Jingyuan Zhang, et al.. (2023). Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer. Computers in Biology and Medicine. 161. 107066–107066. 27 indexed citations

12.

Zhai, Yiyan, Xinkui Liu, Zhihong Huang, et al.. (2023). Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma. Scientific Reports. 13(1). 1373–1373. 19 indexed citations

13.

Zhang, Jingyuan, Fanqin Zhang, Shan Lu, et al.. (2023). Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma. Computers in Biology and Medicine. 165. 107402–107402. 42 indexed citations

14.

Huang, Zhihong, Chao Wu, Xinkui Liu, et al.. (2022). Single-Cell and Bulk RNA Sequencing Reveal Malignant Epithelial Cell Heterogeneity and Prognosis Signatures in Gastric Carcinoma. Cells. 11(16). 2550–2550. 10 indexed citations

15.

Shi, Rui, Haojia Wang, Jingyuan Zhang, et al.. (2022). Investigation on the efficiency of Brucea javanica oil emulsion injection with chemotherapy for treating malignant pleural effusion: A meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 13. 998218–998218. 3 indexed citations

16.

Zhang, Jingyuan, Xinkui Liu, Zhihong Huang, et al.. (2022). T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing. Computers in Biology and Medicine. 152. 106460–106460. 17 indexed citations

17.

Li, Chaonan, et al.. (2022). Lactoferrin Alleviates Lipopolysaccharide-Induced Infantile Intestinal Immune Barrier Damage by Regulating an ELAVL1-Related Signaling Pathway. International Journal of Molecular Sciences. 23(22). 13719–13719. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact